根据文章第一段“A study showed that people who develop Parkinson's disease (帕金森病) before age 50 may trace its origin before birth. The research points to a drug that may potentially help correct these disease processes.”(一项研究表明,在50岁之前患上帕金森氏症的人可能在出生前就找到了病因...
Parkinson’s disease is caused by the deposition of Lewy body in substantia nigra (part of basal ganglia) leads to the death of dopaminergic neurons and subsequent symptoms from dopamine deficiency. 1.Lewy body意为"路易体",主要是由一种叫做alpha synuclein"α...
mHealth researchers are reporting that wearables combined with an AI platform can help healthcare providers track the severity of Parkinson’s disease. As reported in a recent issue ofNature, a team of researchers from IBM, the Pfizer Innovation Research Lab, Boston University’s Spi...
Parkinson's disease (PD) is a neurodegenerative disorder characterized by a loss of substantia nigra (SN) dopaminergic neurons. The etiology of PD remains unknown. This study proposes that prenatal exposure to methanol (MeOH) will sensit... VR Mackey,CG Charlton - 《Faseb Journal》 被引量: ...
OBJECTIVE: To investigate the feasibility of radiolabelled annexin V imaging for early diagnosis of Parkinson's disease. METHODS: 99mTc-HYNIC-annexin V was prepared and its binding to apoptotic cell models of Parkinson's disease was studied in vitro. Cellular models of Parkinson's disease were pro...
Although motor fluctuation can often be severe in Parkinson's disease (PD), it is rare for an 'off period' to result in coma. The case presented here is of a patient with longstanding PD who was admitted to our hospital with a Glasgow Coma Scale of three after missing just one or two...
"For those of us who have Parkinson's, we don't have a cure,” Jaffe said. “I mean, if we can slow the disease or change the outcome, we'll take what we can get. And so I'll be cycling for as long as I have to." ...
Conclusions Results from our study revealed that the IL-10 (−1082G>A, −592C>A) polymorphism is not a risk factor of sporadic Parkinson's disease in a Polish population. 展开 关键词: Parkinson's disease Interleukin-10 Genetic polymorphism ...
ClinicalTrials数据库提供临床试验Clinical Study of Stalevo in the Treatment of Early Parkinson's Disease的登记号NCT04952194,试验分期Phase 4以及申办者Second Affiliated Hospital, School of Medicine, Zhejiang University的信息,更过关于临床试验的其他信息查询就
ClinicalTrials数据库提供临床试验Parkinson's Disease and Movement Disorders Clinical Database的登记号NCT04997642,试验分期以及申办者University of Pennsylvania的信息,更过关于临床试验的其他信息查询就在戊戌数据美国临床试验数据库.